Page last updated: 2024-08-23

sufentanil and Prostatic Neoplasms

sufentanil has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Citro, R; Collura, D; D'Urso, L; Grassano, MT; Grosso, P; Guglielminotti, E; Guglielmotti, E; Macchiarulo, R; Muto, G; Rivalta, L; Valz, C1

Other Studies

1 other study(ies) available for sufentanil and Prostatic Neoplasms

ArticleYear
Transrectal-HIFU as primary minimally-invasive option for localized prostate cancer. Is spinal anaesthesia cost-effective? A single centre experience in over 100 patients.
    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2009, Volume: 81, Issue:1

    Topics: Adjuvants, Anesthesia; Aged; Anesthesia, Spinal; Anesthetics, Local; Bupivacaine; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Italy; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Retrospective Studies; Subarachnoid Space; Sufentanil; Treatment Outcome; Ultrasound, High-Intensity Focused, Transrectal

2009